Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Multiple Myeloma × 13-valent pneumococcal vaccine × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Cyclophosphamide 17 fludarabine phosphate 11 Peripheral Blood Stem Cell Transplantation 10 Cyclosporine 10 fludarabine 9 Whole-Body Irradiation 9 Exercise 8 Dexamethasone 8 Blood Specimen Collection 8 Antilymphocyte Serum 8 Mycophenolic Acid 7 Standard of Care 6 Radiotherapy 6 Melphalan 6 Filgrastim 6 Busulfan 6 Acupuncture Therapy 6 Palliative Care 5 Educational Status 5 Behavior Therapy 5 Therapeutics 4 Surveys and Questionnaires 4 Stem Cell Transplantation 4 Psychiatric Rehabilitation 4 Practice Guidelines as Topic 4 Interviews as Topic 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 thymoglobulin 3 pomalidomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01852591 2017-02-02

PCV13

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed

8 enrolled 10 charts

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡